Literature DB >> 16872369

Addictive drugs and their relationship with infectious diseases.

Herman Friedman1, Susan Pross, Thomas W Klein.   

Abstract

The use of drugs of abuse, both recreationally and medicinally, may be related to serious public health concerns. There is a relationship between addictive drugs of abuse such as alcohol and nicotine in cigarette smoke, as well as illegal drugs such as opiates, cocaine and marijuana, and increased susceptibility to infections. The nature and mechanisms of immunomodulation induced by such drugs of abuse are described in this review. The effects of opiates and marijuana, using animal models as well as in vitro studies with immune cells from experimental animals and humans, have shown that immunomodulation induced by these drugs is mainly receptor-mediated, either directly by interaction with specific receptors on immune cells or indirectly by reaction with similar receptors on cells of the nervous system. Similar studies also show that cocaine and nicotine have marked immunomodulatory effects, which are mainly receptor-mediated. Both cocaine, an illegal drug, and nicotine, a widely used legal addictive component of cigarettes, are markedly immunomodulatory and increase susceptibility to infection. The nature and mechanism of immunomodulation induced by alcohol, the most widely used addictive substance of abuse, are similar but immunomodulatory effects, although not receptor-mediated. The many research studies on the effects of these drugs on immunity and increased susceptibility to infectious diseases, including AIDS, are providing a better understanding of the complex interactions between immunity, infections and substance abuse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16872369     DOI: 10.1111/j.1574-695X.2006.00097.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  64 in total

1.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

2.  Immune to addiction: the ethical dimensions of vaccines against substance abuse.

Authors:  Michael J Young; Dominic A Sisti; Hila Rimon-Greenspan; Jason L Schwartz; Arthur L Caplan
Journal:  Nat Immunol       Date:  2012-05-18       Impact factor: 25.606

Review 3.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).

Authors:  Morena Caira; Anna Candoni; Luisa Verga; Alessandro Busca; Mario Delia; Annamaria Nosari; Cecilia Caramatti; Carlo Castagnola; Chiara Cattaneo; Rosa Fanci; Anna Chierichini; Lorella Melillo; Maria Enza Mitra; Marco Picardi; Leonardo Potenza; Prassede Salutari; Nicola Vianelli; Luca Facchini; Monica Cesarini; Maria Rosaria De Paolis; Roberta Di Blasi; Francesca Farina; Adriano Venditti; Antonella Ferrari; Mariagrazia Garzia; Cristina Gasbarrino; Rosangela Invernizzi; Federica Lessi; Annunziata Manna; Bruno Martino; Gianpaolo Nadali; Massimo Offidani; Laura Paris; Vincenzo Pavone; Giuseppe Rossi; Antonio Spadea; Giorgina Specchia; Enrico Maria Trecarichi; Adriana Vacca; Simone Cesaro; Vincenzo Perriello; Franco Aversa; Mario Tumbarello; Livio Pagano
Journal:  Haematologica       Date:  2015-02       Impact factor: 9.941

5.  Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.

Authors:  Frank M Orson; Roger D Rossen; Xiaoyun Shen; Angel Y Lopez; Yan Wu; Thomas R Kosten
Journal:  Am J Addict       Date:  2013-02-01

6.  HIV-infected individuals who use alcohol and other drugs, and virologic suppression.

Authors:  Seonaid Nolan; Alexander Y Walley; Timothy C Heeren; Gregory J Patts; Alicia S Ventura; Meg M Sullivan; Jeffrey H Samet; Richard Saitz
Journal:  AIDS Care       Date:  2017-05-17

7.  Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.

Authors:  Arame Thiam-Diouf; Barbara Metch; Cameron Sharpe; Robel Mulugeta; Michele Peake Andrasik
Journal:  Vaccine       Date:  2018-02-21       Impact factor: 3.641

8.  Critical Role of Beclin1 in HIV Tat and Morphine-Induced Inflammation and Calcium Release in Glial Cells from Autophagy Deficient Mouse.

Authors:  Jessica Lapierre; Myosotys Rodriguez; Chet Raj Ojha; Nazira El-Hage
Journal:  J Neuroimmune Pharmacol       Date:  2018-05-11       Impact factor: 4.147

9.  Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating anti-HIV-1 miRNA expression.

Authors:  Chinmay K Mantri; Jyoti V Mantri; Jui Pandhare; Chandravanu Dash
Journal:  Am J Pathol       Date:  2013-10-26       Impact factor: 4.307

10.  Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

Authors:  Erinn S Raborn; Guy A Cabral
Journal:  J Pharmacol Exp Ther       Date:  2010-01-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.